Published in Int Surg on April 21, 2006
The Evolving Nature of Hepatic Abscess: A Review. J Clin Transl Hepatol (2016) 0.75
Risk factors contributing to early and late phase intrahepatic recurrence of hepatocellular carcinoma after hepatectomy. J Hepatol (2003) 6.14
Prognostic impact of anatomic resection for hepatocellular carcinoma. Ann Surg (2005) 4.13
One thousand fifty-six hepatectomies without mortality in 8 years. Arch Surg (2003) 3.84
Phase III study of sorafenib after transarterial chemoembolisation in Japanese and Korean patients with unresectable hepatocellular carcinoma. Eur J Cancer (2011) 2.81
Marginal survival benefit in the treatment of early hepatocellular carcinoma. J Hepatol (2012) 2.77
Surgical resection vs. percutaneous ablation for hepatocellular carcinoma: a preliminary report of the Japanese nationwide survey. J Hepatol (2008) 2.64
Prophylactic impact of endoscopic treatment for esophageal varices in liver resection: a prospective study. J Gastroenterol (2013) 2.08
Selection criteria for repeat hepatectomy in patients with recurrent hepatocellular carcinoma. Ann Surg (2003) 2.01
Long-term outcome of extended hemihepatectomy for hilar bile duct cancer with no mortality and high survival rate. Ann Surg (2003) 2.00
Development of evidence-based clinical guidelines for the diagnosis and treatment of hepatocellular carcinoma in Japan. Hepatol Res (2008) 1.91
Phase I trial of a glypican-3-derived peptide vaccine for advanced hepatocellular carcinoma: immunologic evidence and potential for improving overall survival. Clin Cancer Res (2012) 1.84
Acute Appendicitis in an Incarcerated Femoral Hernia: A Case of De Garengeot Hernia. Case Rep Gastroenterol (2009) 1.67
Clinical significance of extrahepatic bile duct resection for advanced gallbladder cancer. J Surg Oncol (2006) 1.56
Combined hepatocellular and cholangiocarcinoma: a clinicopathologic study of 26 resected cases. Jpn J Clin Oncol (2003) 1.50
Transfusion criteria for fresh frozen plasma in liver resection: a 3 + 3 cohort expansion study. Arch Surg (2011) 1.50
Evaluation of hepatic venous congestion: proposed indication criteria for hepatic vein reconstruction. Ann Surg (2002) 1.43
Chimeric acceleration by donor CD4+CD25+T-reg depleted fraction in splenocyte transplantation. J Surg Res (2012) 1.41
Systemic administration of IL-23 induces potent antitumor immunity primarily mediated through Th1-type response in association with the endogenously expressed IL-12. J Immunol (2007) 1.40
Endoscopic prediction of hepatocellular carcinoma by evaluation of bleeding esophageal varices. Digestion (2004) 1.39
Prognostic factors of surgical resection in middle and distal bile duct cancer: an analysis of 55 patients concerning the significance of ductal and radial margins. Surgery (2005) 1.32
Outcomes after emergency surgery for gastric perforation or severe bleeding in patients with gastric cancer. J Surg Oncol (2002) 1.31
Evidence-based Clinical Practice Guidelines for Hepatocellular Carcinoma: The Japan Society of Hepatology 2013 update (3rd JSH-HCC Guidelines). Hepatol Res (2015) 1.23
Management of perforated gastric carcinoma: a report of 16 cases and review of world literature. Am Surg (2002) 1.19
Expression of L-type amino acid transporter 1 (LAT1) in esophageal carcinoma. J Surg Oncol (2005) 1.17
alpha-Fetoprotein mRNA in the circulation as a predictor of postsurgical recurrence of hepatocellular carcinoma: a prospective study. Hepatology (2002) 1.16
Management of hepatocellular carcinoma: Report of Consensus Meeting in the 45th Annual Meeting of the Japan Society of Hepatology (2009). Hepatol Res (2010) 1.11
Pringle's manoeuvre in living donors. Lancet (2002) 1.08
Collision tumor of the stomach: a rare case of an adenocarcinoma and carcinoid tumor. Arch Pathol Lab Med (2005) 1.07
Mortality for gastric cancer in elderly patients. J Surg Oncol (2003) 1.05
Reduced transforming growth factor-beta receptor II expression in hepatocellular carcinoma correlates with intrahepatic metastasis. Lab Invest (2010) 1.04
p16INK4A hypermethylation is associated with hepatitis virus infection, age, and gender in hepatocellular carcinoma. Clin Cancer Res (2004) 1.01
Recent advances in chemotherapy for advanced gastric cancer in Japan. Surg Today (2010) 1.00
Uracil-tegafur as an adjuvant for hepatocellular carcinoma: a randomized trial. Hepatology (2006) 1.00
Right lateral sector graft in adult living-related liver transplantation. Transplantation (2002) 1.00
Inhibition of MMP-9 transcription and suppression of tumor metastasis by pyrrole-imidazole polyamide. Cancer Sci (2009) 1.00
Programmed death-1-programmed death-L1 interaction is essential for induction of regulatory cells by intratracheal delivery of alloantigen. Transplantation (2004) 0.99
Value of highly sensitive fucosylated fraction of alpha-fetoprotein for prediction of hepatocellular carcinoma recurrence after curative treatment. Dig Dis Sci (2013) 0.98
Fungal metabolite gliotoxin blocks mast cell activation by a calcium- and superoxide-dependent mechanism: implications for immunosuppressive activities. Clin Immunol (2005) 0.98
Sera from liver failure patients and a demethylating agent stimulate transdifferentiation of murine bone marrow cells into hepatocytes in coculture with nonparenchymal liver cells. J Hepatol (2003) 0.97
FLEP chemotherapy for alpha-fetoprotein-producing gastric cancer. Oncology (2004) 0.97
An evaluation of the effectiveness of extended lymph node dissection in patients with gastric cancer: a retrospective study of 1403 cases at a single institution. J Surg Res (2002) 0.97
Isolated tuberculous liver abscess invading the abdominal wall: report of a case. Surg Today (2011) 0.97
Effectiveness of hepatic resection for early-stage hepatocellular carcinoma in cirrhotic patients: subgroup analysis according to Milan criteria. Jpn J Clin Oncol (2007) 0.95
Distinct gene expression of osteopontin in patients with ulcerative colitis. J Surg Res (2003) 0.95
A comparison of the surgical outcomes among patients with HBV-positive, HCV-positive, and non-B non-C hepatocellular carcinoma: a nationwide study of 11,950 patients. Ann Surg (2015) 0.94
Progress in surgical treatment of hepatocellular carcinoma. Oncology (2002) 0.93
Clinical significance of early hepatocellular carcinoma. Liver Transpl (2004) 0.93
Current approaches to the treatment of early hepatocellular carcinoma. Oncologist (2010) 0.93
Safe donor hepatectomy for living related liver transplantation. Liver Transpl (2002) 0.93
Gd-EOB-DTPA-enhanced magnetic resonance imaging and alpha-fetoprotein predict prognosis of early-stage hepatocellular carcinoma. Hepatology (2014) 0.92
Macroscopic portal vein tumor thrombi of liver metastasis from colorectal cancer. J Hepatobiliary Pancreat Surg (2008) 0.92
Bacterial neuraminidase rescues influenza virus replication from inhibition by a neuraminidase inhibitor. PLoS One (2012) 0.92
Selective cyclooxygenase 2 inhibitor induces indefinite survival of fully allogeneic cardiac grafts and generates CD4+ regulatory cells. J Thorac Cardiovasc Surg (2005) 0.92
D2 gastrectomy with versus without bursectomy for gastric cancer. Am J Clin Oncol (2014) 0.92
Survivin as a prognostic factor for osteosarcoma patients. Acta Histochem Cytochem (2006) 0.91
Neoadjuvant chemotherapy with S-1 and CDDP in advanced gastric cancer. J Cancer Res Clin Oncol (2006) 0.91
Association between pretransplant psychological assessments and posttransplant psychiatric disorders in living-related transplantation. Psychosomatics (2002) 0.90
Endovascular stenting for celiac axis stenosis before pancreaticoduodenectomy. Surgery (2003) 0.89
Multistep and multicentric development of hepatocellular carcinoma: histological analysis of 980 resected nodules. J Hepatol (2005) 0.89
Impaired volume regeneration of split livers with partial venous disruption: a latent problem in partial liver transplantation. Transplantation (2002) 0.89
Bioresorbable membrane to reduce postoperative small bowel obstruction in patients with gastric cancer: a randomized clinical trial. Ann Surg (2008) 0.89
Interleukin-10 but not transforming growth factor-beta is essential for generation and suppressor function of regulatory cells induced by intratracheal delivery of alloantigen. Transplantation (2005) 0.88
Resection of solitary metachronous lymph node metastasis from hepatocellular carcinoma following transarterial chemotherapy with cisplatin: a case report. Anticancer Res (2011) 0.88
Effect of gastrectomy on the pharmacokinetics of S-1, an oral fluoropyrimidine, in resectable gastric cancer patients. Cancer Chemother Pharmacol (2007) 0.88
Role of splenectomy in living-donor liver transplantation for adults. Hepatogastroenterology (2002) 0.88
Caudate lobectomy (segmentectomy 1) (with video). J Hepatobiliary Pancreat Sci (2012) 0.87
Gastrointestinal bleeding after living-related liver transplantation. Dig Dis Sci (2002) 0.87
Staged approach to the urachal cyst with infected omphalitis. Int Surg (2006) 0.87
Preoperative portal embolization in patients with hepatocellular carcinoma. World J Surg (2001) 0.87
Characteristics of ectopic pancreas in dynamic gadolinium-enhanced MRI. Abdom Imaging (2008) 0.86
Exophytic primary squamous cell carcinoma of the stomach. J Gastroenterol (2004) 0.86
Validation of perioperative steroids administration in liver resection: a randomized controlled trial. Ann Surg (2011) 0.86
Irinotecan plus S-1 for liver metastases of gastric cancer. Hepatogastroenterology (2010) 0.85
Measurement of extra-pancreatic secretory function by 13C-dipeptide breath test. Transl Res (2007) 0.85
Single-incision laparoscopic surgery used to perform transanal endoscopic microsurgery (SILSTEM) for T1 rectal cancer under spinal anesthesia: report of a case. Surg Today (2012) 0.84
Osteopontin expression in ulcerative colitis is distinctly different from that in Crohn's disease and diverticulitis. J Gastroenterol (2005) 0.84
Effect of hypoventilation on bleeding during hepatic resection: a randomized controlled trial. Arch Surg (2002) 0.84
Duct-to-duct biliary reconstruction in living-related liver transplantation. Transplantation (2002) 0.84
L-[1-13C] phenylalanine breath test reflects histological changes in the liver. J Surg Res (2003) 0.84
Expression of transforming growth factor-alpha and -beta in hepatic lobes after hemihepatic portal vein embolization. Dig Dis Sci (2006) 0.83
High dose of antithrombin III induces indefinite survival of fully allogeneic cardiac grafts and generates regulatory cells. Transplantation (2003) 0.83
Decreased blood loss reduces postoperative complications in resection for hepatocellular carcinoma. J Hepatobiliary Pancreat Sci (2014) 0.83
A case of gastritis cystica profunda. Surgery (2008) 0.83
Early cancer-related death after resection of hepatocellular carcinoma. Surgery (2010) 0.82
Complete remission by transarterial infusion with cisplatin for recurrent bile duct tumor thrombus of hepatocellular carcinoma: report of a case. World J Surg Oncol (2013) 0.82
A combination of oral uracil-tegafur plus leucovorin (UFT + LV) is a safe regimen for adjuvant chemotherapy after hepatectomy in patients with colorectal cancer: safety report of the UFT/LV study. Drug Discov Ther (2014) 0.82
Genomic approach towards personalized anticancer drug therapy. Pharmacogenomics (2012) 0.82
The risk factors of fungal infection in living-donor liver transplantations. J Hepatobiliary Pancreat Sci (2012) 0.81
Complete remission of disease for 5 years following initial and repeat resection of the liver for the removal of 22 metastases of colorectal origin. J Hepatobiliary Pancreat Surg (2003) 0.81
[Bacteria isolated from surgical infections and its susceptibilities to antimicrobial agents--special references to bacteria isolated between April 2003 and March 2004]. Jpn J Antibiot (2005) 0.81
Proposal of objective morphological classification system for hepatocellular carcinoma using preoperative multiphase computed tomography. J Gastroenterol (2013) 0.81
Anatomical segmentectomy of the pancreas head: can this procedure be curatively applied for intraductal papillary mucinous tumors? Pancreas (2003) 0.81
Phenylalanine breath test as a method to evaluate hepatic dysfunction in obstructive jaundice. J Surg Res (2005) 0.81
Two cases of primary malignant fibrous histiocytoma of the liver: immunohistochemical expression of ezrin and its relationship with prognosis. Acta Histochem Cytochem (2009) 0.81
Accuracy of the preoperative determination of tumor markers in the differentiation of liver mass lesions in surgical patients. Hepatogastroenterology (2002) 0.81